Pheromonicins: An ecologically sound family of bacteriocin-based antibiotics for use in the age of the microbiome

Future Microbiology

Volumn 10, Issue 12, 2015, Pages 1969-1979

  Qiu, Xiao Qing ^a   Roy, Sandra M ^b   Riley, Margaret A ^b  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

alternatives to antibiotics; antibiotics; anticancer cells; antifungals; antivirals; bacteriocins; designer drugs; infection control; pheromonicins

Indexed keywords

ANTIBIOTIC AGENT; BACTERIOCIN; COLICIN; PHEROMONICIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CANCER CELL; DRUG DESIGN; DRUG INDUSTRY; DRUG POTENCY; ESCHERICHIA COLI; HUMAN; INFECTION CONTROL; LIPID BILAYER; MICROBIOME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOMYCES; STRUCTURE ACTIVITY RELATION; TARGET CELL; TUMOR GROWTH; DRUG DEVELOPMENT; ISOLATION AND PURIFICATION; PROCEDURES;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BACTERIOCINS; DRUG DISCOVERY; HUMANS;

EID: 84948400470     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.104     Document Type: Article

References (36)

1. Busti E, Monciardini P, Cavaletti L et al. Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes. Microbiology 152(Pt 3), 675-683 (2006).
2. Watve MG, Tickoo R, Jog MM, Bhole BD. How many antibiotics are produced by the genus streptomyces Arch. Microbiol. 176(5), 386-390 (2001).
3. Berdy J. Bioactive microbial metabolites. J. Antibiot. (Tokyo) 58(1), 1-26 (2005).
4. Blaser M. Antibiotic overuse: stop the killing of beneficial bacteria. Nature 476(7361), 393-394 (2011).
5. Riley MA, Robinson SM, Roy CM, Dorit RL. Rethinking the composition of a rational antibiotic arsenal for the 21st century. Future Med. Chem. 5(11), 1231-1242 (2013).
6. Braun V, Pilsl H, Gross P. Colicins: structures, modes of action, transfer through membranes, and evolution. Arch. Microbiol. 161(3), 199-206 (1994).
7. Konisky J. Colicins and other bacteriocins with established modes of action. Annu. Rev. Microbiol. 36, 125-144 (1982).
8. Tagg JR, Dajani AS, Wannamaker LW. Bacteriocins of gram-positive bacteria. Bacteriol. Rev. 40(3), 722-756 (1976).
9. Cotter PD, Ross RP, Hill C. Bacteriocins-a viable alternative to antibiotics Nat. Rev. Microbiol. 11(2), 95-105 (2013).
10. Jacob F, Siminovitch L, Wollman E. Sur la biosynthése d'une colicine et sur son mode d'action. Ann. Inst. Pasteur 83, 295-315 (1952).
11. Jakes KS, Abrams CK, Finkelstein A, Slatin SL. Alteration of the pH-dependent ion selectivity of the colicin E1 channel by site-directed mutagenesis. J. Biol. Chem. 265(12), 6984-6991 (1990).
12. Mankovich JA, Hsu CH, Konisky J. DNA and amino acid sequence analysis of structural and immunity genes of colicins Ia and Ib. J. Bacteriol. 168(1), 228-236 (1986).
13. Wiener M, Freymann D, Ghosh P, Stroud RM. Crystal structure of colicin Ia. Nature 385(6615), 461-464 (1997).
14. Qiu XQ, Jakes KS, Kienker PK, Finkelstein A, Slatin SL. Major transmembrane movement associated with colicin Ia channel gating. J. Gen. Physiol. 107(3), 313-328 (1996).
15. Qiu XQ, Tong CY, Zhong ZQ et al. An engineered multidomain fungicidal peptide against plant fungal pathogens. Sheng Li Xue Bao 65(4), 417-432 (2013).
16. Qiu XQ. Abstr. Soc. Neurosci. 27, 812-824 (2001).
17. Nogueira RA, Varanda WA. Gating properties of channels formed by colicin Ia in planar lipid bilayer membranes. J. Membr. Biol. 105(2), 143-153 (1988).
18. Slatin SL, Qiu XQ, Jakes KS, Finkelstein A. Identification of a translocated protein segment in a voltage-dependent channel. Nature 371(6493), 158-161 (1994).
19. Qiu XQ, Jakes KS, Finkelstein A, Slatin SL. Site-specific biotinylation of colicin Ia. A probe for protein conformation in the membrane. J. Biol. Chem. 269(10), 7483-7488 (1994).
20. Qiu XQ, Zhang J, Wang H, Wu GY. A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycinresistant enterococcus faecalis. Antimicrob. Agents Chemother. 49(3), 1184-1189 (2005).
21. Feldgarden M, Riley MA. High levels of colicin resistance in Escherichia coli. Evolution 52(5), 1270-1276 (1998).
22. Gravesen A, Jydegaard Axelsen AM, Mendes Da Silva J, Hansen TB, Knochel S. Frequency of bacteriocin resistance development and associated fitness costs in listeria monocytogenes. Appl. Environ. Microbiol. 68(2), 756-764 (2002).
23. Kjos M, Nes IF, Diep DB. Mechanisms of resistance to bacteriocins targeting the mannose phosphotransferase system. Appl. Environ. Microbiol. 77(10), 3335-3342 (2011).
24. Opsata M, Nes IF, Holo H. Class IIa bacteriocin resistance in Enterococcus faecalis V583: the mannose PTS operon mediates global transcriptional responses. BMC Microbiol. 10, 224 (2010).
25. Qiu XQ, Wang H, Lu XF et al. An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria. Nat. Biotechnol. 21(12), 1480-1485 (2003).
26. Dunny GM, Leonard BA. Cell-cell communication in gram-positive bacteria. Annu. Rev. Microbiol. 51, 527-564 (1997).
27. Jarraud S, Lyon GJ, Figueiredo AM et al. Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J. Bacteriol. 182(22), 6517-6522 (2000).
28. Ji G, Beavis RC, Novick RP. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc. Natl Acad. Sci. USA 92(26), 12055-12059 (1995).
29. Vandenesch F, Kornblum J, Novick RP. A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J. Bacteriol. 173(20), 6313-6320 (1991).
30. Otto M, Echner H, Voelter W, Gotz F. Pheromone cross-inhibition between Staphylococcus aureus and Staphylococcus epidermidis. Infect. Immun. 69(3), 1957-1960 (2001).
31. Van Leeuwen W, Van Nieuwenhuizen W, Gijzen C, Verbrugh H, Van Belkum A. Population studies of methicillin-resistant and-sensitive Staphylococcus aureus strains reveal a lack of variability in the agrd gene, encoding a staphylococcal autoinducer peptide. J. Bacteriol. 182(20), 5721-5729 (2000).
32. Hancock L, Perego M. Two-component signal transduction in Enterococcus faecalis. J. Bacteriol. 184(21), 5819-5825 (2002).
33. Buttaro BA, Antiporta MH, Dunny GM. Cell-associated pheromone peptide (cCF10) production and pheromone inhibition in Enterococcus faecalis. J. Bacteriol. 182(17), 4926-4933 (2000).
34. Haas W, Shepard BD, Gilmore MS. Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction. Nature 415(6867), 84-87 (2002).
35. Zhu YH, Liu PQ, Weng XG et al. Short communication: pheromonicin-SA affects mRNA expression of toll-like receptors, cytokines, and lactoferrin by Staphylococcus aureus-infected bovine mammary epithelial cells. J. Dairy Sci. 95(2), 759-764 (2012).
36. Qiu XQ, Wang H, Cai B, Wang LL, Yue ST. Small antibody mimetics comprising two complementarity-determining regions and a framework region for tumor targeting. Nat. Biotechnol. 25(8), 921-929 (2007).